Latest Regulatory News

Killi Resources Limited has successfully completed the first tranche of its share placement, issuing over 26 million shares to raise just over $1 million. The company confirms full regulatory compliance with no undisclosed information.

Kjerulf David Hastings Ainsworth has initiated a second unconditional off-market takeover bid for 5.5% of Ainsworth Game Technology shares at a significant premium, aiming to increase his stake and influence in the company.

Lumos Diagnostics has secured a pivotal US FDA CLIA waiver for its FebriDx® test, vastly expanding its market reach and triggering milestone payments that bolster its US commercial rollout.

Bass Oil reported steady February production with some operational setbacks in the Cooper Basin, while gaining regulatory approval for the Vanessa gas field acquisition and securing government funding for Kiwi gas development.

4DMedical has achieved CE Mark certification for its groundbreaking CT:VQ™ ventilation-perfusion imaging technology, unlocking the vast European market. The company also raised $83 million to fund rapid expansion across the EU.

AdAlta’s subsidiary AdCella has completed its first Joint Development Committee meeting with Shanghai Cell Therapy Group, advancing the development of the CAR-T therapy BZDS1901 with potential timeline acceleration and reduced regulatory risks.

Unity Metals has reported promising high-grade gold intersections from initial drilling at its Ngot Gold Project, with assays confirming mineralisation similar to the nearby Okvau Mine. The ongoing 8,000m drilling program is progressing well, with further results eagerly awaited.

Marvel Gold has identified promising new mineralisation corridors at its Hanang Gold Project in Tanzania following an extensive drone magnetic survey, setting the stage for a maiden drilling campaign starting in April.

HyTerra Limited has partnered with Omani operator ARA Natural Resources to explore geologic hydrogen opportunities in Oman’s Semail Ophiolite, aiming to pioneer commercialisation in a promising low-carbon energy frontier.

Firebrick Pharma has secured its first regulatory approval for Nasodine Nasal Spray in Indonesia, paving the way for entry into Southeast Asia’s largest market. This milestone marks a significant step in the company’s international expansion strategy.

MyEco Group launches a $2 million Series 2 convertible note offer targeting sophisticated investors, featuring a 10.5% annual interest and a 15% discount on share conversion prices.

InFocus Group Holdings has completed Codexa, a proprietary sweepstakes casino platform targeting the booming US market, with plans for licensing and potential sale.